Skip to main content
. 2018 Mar 20;13(3):e0194754. doi: 10.1371/journal.pone.0194754

Table 1. Demographic and clinical characteristics of HIV+ persons and frequency-matched controls.

HIV+ (N = 5052) Controls (N = 10121) P-value
Age (years) 48.2 ± 11.6 48.2 ± 11.4 0.68
18–30, N (%) 331 (6.6%) 647 (6.4%) 0.98
31–40 921 (18.3%) 1871 (18.5%)
41–50 1451 (28.8%) 2886 (28.5%)
51–60 1615 (32.0%) 3291 (32.5%)
61–70 590 (11.7%) 1159 (11.4%)
>70 133 (2.6%) 267 (2.6%)
Race (N, %) <0.01
White 1680 (34.5%) 3207 (39.9%)
Black 1573 (32.3%) 2698 (33.5%)
Hispanic 173 (3.6%) 359 (4.5%)
Other/Unknown 1438 (29.6%) 1783 (22.2%)
Male (N, %) 4167 (82.5%) 8381 (82.8%) 0.13
Body-Mass Index (kg/m2) 25.9 ± 5.6 28.6 ± 6.5 <0.01
Total cholesterol (mg/dl) 202.2 ± 59.1 194.5 ± 50.6 <0.01
HDL cholesterol (mg/dl) 34.3 ± 13.1 42.9 ± 14.1 <0.01
Hepatitis C Virus (N, %) 425 (8.4%) 90 (0.9%) <0.01
Hypertension (N, %) 1674 (33.1%) 1893 (18.7%) <0.01
Diabetes (N, %) 463 (9.2%) 603 (6.0%) <0.01
Coronary Heart Disease (N, %) 728 (14.4%) 704 (7.0%) <0.01
Myocardial Infarction (N, %) 571 (11.3%) 502 (5.0%) <0.01
Chronic Obstructive Pulmonary Disease (N, %) 305 (6.0%) 223 (2.2%) <0.01
Stroke, N (%) 316 (6.3%) 281 (2.8%) <0.01
Atrial Fibrillation (N, %) 101 (2.00%) 159 (1.57%) 0.056
CHADS Score (N, %) <0.01
0 2915 (57.8%) 7784 (76.9%)
1 1213 (24.1%) 1354 (13.4%)
2 509 (10.1%) 601 (5.9%)
3 226 (4.5%) 220 (2.2%)
4 125 (2.5%) 100 (1.0%)
5 47 (0.9%) 54 (0.5%)
6 6 (0.1%) 8 (0.1%)
CHADS Score <2 (N, %) 4128 (81.9%) 9138 (90.3%) <0.01

Note: Continuous variables compared with t-test or nonparametric equivalent; Categorical variables compared with chi-square or nonparametric equivalent; Total cholesterol and HDL cholesterol calculated as peak and nadir, respectively, given several measurements over time